STEM-13. CANCER STEM CELL CYTOTOXICITY ASSAY-GUIDED TREATMENT IN RECURRENT GLIOBLASTOMA AND PROGRESSIVE ANAPLASTIC GLIOMA

BACKGROUND: The presence of chemotherapy-resistant cancer stem cells (CSC) leading to tumor recurrence is postulated to be one of the major factors in the poor response to the current standard of care treatments in progressive high-grade gliomas. Unfortunately, in spite of several new drug discoveri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Ranjan, Tulika, Howard, Candace, Yu, Alexander, Xu, Linda, Aziz, Khaled, Jho, David, Leonardo, Jodi, Hameed, Muhammad, Karlovits, Stephen, Wegner, Rodney, Fuhrer, Russell, Lirette, Seth, Denning, Krista, Valluri, Jagan, Paolo Claudio, Pier
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Stem Cells
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847352/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.987
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares